Health ❯ Healthcare ❯ Patient Care

Treatment Strategies

Combination Therapy Personalized Medicine Quality of Life Early Intervention Radiation Dose Adjustment Dopamine Signaling Imaging Techniques Second-Line Therapy Risk Assessment Monoclonal Antibodies Precision Medicine Patient Preferences Invasive Management Maintenance Therapy Exercise and Medication Cardiac Safety Post-Operative Care Drug Resistance Lymphatic Dysfunction Recurrence Prevention Bone Quality Improvement Individualized Treatment Anti-inflammatory Therapy Medication Management Treatment Sequencing Hormone Receptor-Positive Breast Cancer Lifestyle Management Adverse Effects

FDA Approves Camizestrant for ESR1‑Mutated Advanced Breast Cancer

The decision lets doctors switch an aromatase inhibitor to the oral SERD camizestrant after a blood test finds an ESR1 resistance mutation, with confirmatory trials required.

EMA Recommends Etcamah for ESR1‑Mutant Advanced Breast Cancer

EMA Validates Astellas Bid to Add Padcev–Keytruda Combo for Perioperative Muscle-Invasive Bladder Cancer

Tucatinib Added to First-Line HER2 Maintenance Prolongs Progression-Free Survival in Phase 3 Trial

GigaTIME AI Converts Routine H&E Slides Into Virtual Spatial Proteomics at Population Scale

Study Finds Blood-Brain Barrier Largely Intact in Key Alzheimer’s Mouse Model

USC Study Identifies Top Mortality Risks in MASLD, With Hypertension Leading

TIM‑3 Triplet Therapy Shows Promise in Immunotherapy‑Resistant Melanoma Models

Danish Real-World Study Finds PSMA PET/CT Before Salvage Radiotherapy Boosts Prostate Cancer Survival

Varenicline-Bupropion Combination Doubles Treatment Effectiveness for Alcohol Use Disorder